Clinical Trial: COMPARISON OF EFFECTIVENESS OF SUBMUCOSAL DEXAMETHASONE AND METHYLPREDNISOLONE IN MANAGEMENT OF POST OPERATIVE SEQUELAE IN MANDIBULAR PARASYMPHYSIS FRACTURES

U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07208799) titled 'COMPARISON OF EFFECTIVENESS OF SUBMUCOSAL DEXAMETHASONE AND METHYLPREDNISOLONE IN MANAGEMENT OF POST OPERATIVE SEQUELAE IN MANDIBULAR PARASYMPHYSIS FRACTURES' on Sept. 28.

Brief Summary: The rationale of the current research is to address the limitation of existing knowledge as it is not clear which of the two drugs (Dexamethasone or Methylprednisolone) is more effective in reduction of postoperative sequelae in patient with mandibular parasymphysis fracture. This study fills the gap by providing sound evidence on the preferred steroid option to help clinicians have more data to make decisions and improve patients' health. The result...